Cervical disc replacement procedure involves minimally invasive surgery that is used in the treatment of degenerative disc disease (DDD). Disc degeneration is a phenomenon associated with aging and occurs in different individuals with varying degree of degeneration. DDD may lead to lower back pain and neck pain. The prevalence of neck pain is comparatively higher in the western countries as compared to Asia Pacific. Moreover, neck pain is more common in women than in men and the risk of developing neck pain is high in the age group of 35 to 49 years. The global cervical total disc replacement device market is estimated to account for US$ 1,106.0 Mn in terms of value by the end of 2019
Global Cervical Total Disc Replacement Device Market: Drivers
Increasing government investment in innovative medical projects is expected to boost growth of the global cervical total disc replacement device market over the forecast period. For instance, in December 2019, the Government of Australia announced to invest over US$ 14.7 million in 17 ground-breaking medical projects. In one of these projects, Kunovus Technologies Pty Ltd. is developing an elastomeric motion-preserving implant for the treatment of lumbar spine osteoarthritis as an alternative to fusion.
Global Cervical Total Disc Replacement Device Market: Opportunities
Increasing adoption of cervical artificial disc replacement in outpatient setting is expected to offer lucrative growth opportunities for players in the global cervical total disc replacement device market. For instance, in November 2019, a study ‘The Safety of Single and Multi-Level Cervical Total Disc Replacement in Ambulatory Surgery Centers’ published in the journal Spine, found that single and multi-level cervical artificial disc replacement was safe and effective in an outpatient setting.
Global Cervical Total Disc Replacement Device Market: Restraints
There is no sufficient evidence that demonstrates the superiority of cervical total disc replacement over anterior cervical discectomy. This in turn is expected to hinder growth of the global cervical total disc replacement device market.
The Metal on Biocompatible segment in the global cervical total disc replacement device market was valued at US$ 794.8 Mn in 2018 and is expected to reach US$ 5,132.5 Mn by 2027 at a CAGR of 23.1% during the forecast period. The growth of the segment is attributed to increasing technological advancement for development of efficient devices during the forecast period. The Hospital segment held dominant position in the global cervical total disc replacement device market in 2018, accounting for 74.9% share in terms of value, followed by ambulatory surgical centers, respectively. The segment growth is attributed to increasing patient population.
Key players in the market are focused on expanding the application of their offerings to enhance their market share. For instance, in November 2019, NuVasive, Inc. received the U.S. FDA 510(k) clearance for expanded indications for the CoRoent Small Interlock system, which can now be used in more than two level procedures. Key players in the market are also focused on commercialization of their products to enhance their market share. For instance, in July 2019, EmergeOrtho, P.A. announced the first implant of M6-C artificial cervical disc for the treatment of cervical disc degeneration.
Global Cervical Total Disc Replacement Device Market: Competitive Landscape
Major players operating in the global cervical total disc replacement device market include, LDR Holdings, Johnson & Johnson Services, Inc., Medtronic, Plc., Centinel Spine LLC, Orthofix Medical Inc., Globus Medical, Inc., and NuVasive, Inc.
Key players in the market are focused on product launch to expand their product portfolio. For instance, in September 2019, NuVasive, Inc. launched Modulus Cervical, a porous titanium interbody implant for cervical applications. Key players in the market are also focused on conducting clinical trials. For instance, in August 2019, Centinel Spine, LLC announced first implantation in an Investigational Device Exemption (IDE) study for evaluating two different cervical total disc replacement (TDR) devices.
“*” marked represents similar segmentation in other categories in the respective section.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.